Worsening of Stroke Patient on Day 7

Neurological Causes

1. Cerebral Edema (Most common early cause)

• Brain edema begins within hours of ischemic stroke and peaks at 72–120 hours (3–5 days), but mass effect and herniation can manifest and extend into day 7, especially in large infarcts.
• Particularly dangerous in younger patients and those with large-artery occlusion (MCA territory, "malignant" infarction).
• Edema is initially cytotoxic (grey matter), then vasogenic (white matter).
• No pharmacological agent is proven effective; corticosteroids are not indicated for ischemic cerebral edema.
• Management: osmotherapy (mannitol/hypertonic saline), head elevation, ICP monitoring, and decompressive hemicraniectomy for malignant MCA infarction.
• — Bradley and Daroff's Neurology in Clinical Practice, p. 1406

2. Hemorrhagic Transformation (HT)

• Petechial or confluent hemorrhage into infarcted tissue, more common in large cardioembolic strokes and after tPA administration.
• Typically occurs 24–72 hours but can occur up to 1 week.
• Risk factors: large infarct size, anticoagulation, hypertension, thrombolysis.
• — Bradley and Daroff's Neurology in Clinical Practice; Robbins Pathologic Basis of Disease

3. Stroke Progression / Recurrent Stroke

• Propagation of thrombus, re-embolism, or hemodynamic failure in borderzone regions.
• Stuttering or stepwise worsening is characteristic of lacunar or large-vessel atherosclerotic strokes.
• Assess for: inadequate antiplatelet/anticoagulation, new cardioembolic source, carotid stenosis.
• DAPT (aspirin + clopidogrel) for 21 days is recommended in minor stroke or high-risk TIA to prevent early recurrence.
• — Goldman-Cecil Medicine

4. Cerebral Vasospasm

• Relevant primarily in subarachnoid hemorrhage (SAH), where vasospasm peaks at days 5–14 and causes delayed cerebral ischemia. In SAH, day 7 is squarely in the danger window.
• — Fuster and Hurst's The Heart

5. Seizures

• Occur in <5% of ischemic stroke patients, but early post-stroke seizures (within first week) can mimic or cause apparent neurological worsening.
• Antiseizure medications should be initiated if a seizure occurs.
• — Bradley and Daroff's Neurology

6. Hydrocephalus

• Especially with cerebellar infarction — swelling can compress the brainstem and cause hydrocephalus, manifesting as drowsiness, Babinski signs, gaze paresis.
• Can present days after the initial event; surgical decompression (suboccipital craniectomy + ventricular drainage) may be needed urgently.
• — Adams and Victor's Principles of Neurology

Systemic / Medical Causes (Particularly Day 5–14)

"In the second through the fourth weeks, pneumonia is the most common cause of non-neurological death." — Bradley and Daroff's Neurology, p. 1407

Systematic Approach at Day 7

1. Repeat brain imaging (CT/MRI) — rule out hemorrhagic transformation, new infarct, expanding edema, hydrocephalus
2. Vitals + fever workup — blood cultures, urine culture, CXR
3. Cardiac monitoring — ECG, troponin, look for arrhythmia (new AF?)
4. Glucose, electrolytes, CBC
5. NIHSS reassessment — quantify deficit change
6. Review medications — BP drugs given inappropriately? Anticoagulation started/withheld?
7. Swallowing assessment — aspiration risk

Summary Table

Ring-Enhancing Lesions & Open-Ring Enhancing Lesions

What is Ring Enhancement?

Causes of Ring-Enhancing Lesions

Mnemonic: "MAGIC DR"

The Open-Ring (Incomplete Ring) Sign

"Incomplete (open) ring enhancement differentiates MS from tumours/abscess. This open ring pattern reflects the less inflammatory reaction of the cortical component of the MS lesion, with less blood-brain barrier disruption and as consequence no contrast uptake." — Grainger & Allison's Diagnostic Radiology

Mechanism

• The open/incomplete side of the ring faces the cortical grey matter
• Grey matter side has less BBB disruption → no enhancement there
• White matter side has active inflammatory demyelination → enhances

Key facts about the open-ring sign:

• Highly specific for demyelinating disease (MS, tumefactive MS, acute disseminated encephalomyelitis — ADEM)
• ~50% of tumefactive MS lesions show this pattern
• Ring is open on the grey-matter side (cortical aspect)
• Rapid suppression by steroid treatment
• Enhancement duration: median 3.1 weeks; rarely beyond 2–3 months (if persistent → suspect neoplasm, sarcoidosis, vascular malformation)
• May evolve from nodular → ring pattern over time

Key Radiological Comparison Table

Illustrated Comparison

Brain Abscess — Specific Ring Features

• Days 1–3: Early cerebritis — irregular enhancement, no ring yet
• Days 4–9: Late cerebritis — early ring formation
• Days 10–13: Ring-enhancing capsule appears (better developed on cortical side than ventricular side)
• Day 14+: Complete, well-formed ring with dense collagenous capsule

• Smooth, thin, uniform ring (vs thick/nodular in tumour)
• DWI bright / ADC dark — restricted diffusion in the pus core is the best differentiator from tumour
• Surrounding vasogenic edema
• Satellite/daughter abscesses are characteristic
• Lower rCBV in enhancing rim vs GBM (perfusion MRI)
• A thick, irregular rim → favours tumour

"Though typical, the appearance of a brain abscess as a rim-enhancing mass is non-specific and may be mimicked by metastasis, glioblastoma and resolving haematoma. A thick, irregular rind of enhancement is more suggestive of tumour." — Grainger & Allison's Diagnostic Radiology

Clinical Approach to a Ring-Enhancing Lesion

1. Immunocompromised (HIV, CD4 <100)? → Toxoplasma first (empirical treatment × 2 weeks, repeat imaging)
   • If no response → CNS lymphoma (biopsy)
2. DWI bright core? → Brain abscess → neurosurgery (aspiration) + antibiotics
3. Open ring (incomplete), periventricular, young patient? → Demyelination (MS/ADEM) → steroids
4. Thick irregular ring, old patient, known primary cancer? → Metastasis
5. Butterfly across corpus callosum? → GBM
6. Immunocompetent + single ring + positive tuberculin/endemic area? → Tuberculoma